Biofrontera (BFRIW) Receivables - Net (2020 - 2025)
Biofrontera has reported Receivables - Net over the past 6 years, most recently at $7.3 million for Q4 2025.
- Quarterly results put Receivables - Net at $7.3 million for Q4 2025, up 37.18% from a year ago — trailing twelve months through Dec 2025 was $7.3 million (up 37.18% YoY), and the annual figure for FY2025 was $7.3 million, up 37.18%.
- Receivables - Net for Q4 2025 was $7.3 million at Biofrontera, up from $3.0 million in the prior quarter.
- Over the last five years, Receivables - Net for BFRIW hit a ceiling of $7.3 million in Q4 2025 and a floor of $1.6 million in Q3 2022.
- Median Receivables - Net over the past 5 years was $3.8 million (2021), compared with a mean of $3.8 million.
- Biggest five-year swings in Receivables - Net: skyrocketed 142.83% in 2023 and later tumbled 38.55% in 2025.
- Biofrontera's Receivables - Net stood at $3.8 million in 2021, then fell by 0.95% to $3.7 million in 2022, then soared by 37.73% to $5.2 million in 2023, then increased by 2.96% to $5.3 million in 2024, then surged by 37.18% to $7.3 million in 2025.
- The last three reported values for Receivables - Net were $7.3 million (Q4 2025), $3.0 million (Q3 2025), and $4.0 million (Q2 2025) per Business Quant data.